Navigation Links
Medicago reports positive Phase I results for its avian flu pandemic vaccine
Date:12/21/2009

non-infectious and unable to replicate. FDA-approved H5N1 influenza vaccines in the United States require two 90-microgram doses, administered at least four weeks apart to achieve appropriate level of antibodies in 44% of vaccinated individuals. Because Medicago's technology requires the genetic sequence of a viral strain and not the live influenza virus, vaccines can be manufactured within four weeks of obtaining the genetic sequence of a pandemic strain. This is in contrast with current manufacturing technologies which rely on strain adaptation and can only deliver a vaccine six to nine months after a pandemic is declared.

About Medicago

Medicago is committed to provide highly effective and affordable vaccines based on proprietary Virus-Like Particle (VLP) and manufacturing technologies. Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine antigens in non-transgenic plants. This technology has potential to offer advantages of speed and cost over competitive technologies. It could deliver a vaccine for testing in about a month after the identification and reception of genetic sequences from a pandemic strain. This production time frame has the potential to allow vaccination of the population before the first wave of a pandemic strikes and to supply large volumes of vaccine antigens to the world market. Additional information about Medicago is available at www.medicago.com.

Forward Looking Statements

This news release includes certain forward-looking statements that are based upon current expectations, which involve risks and uncertainties associated with Medicago's business and the environment in which the Compa
'/>"/>

SOURCE Medicago Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Medicago initiates work on Swine Flu strain
2. Medicago succesfully expresses VLP antigen for A H1N1 strain
3. Medicagos H1N1 pandemic vaccine candidate shows positive response in 100% of vaccinated animals after a single dose
4. Medicago receives regulatory approval to begin human clinical testing with its avian flu pandemic vaccine
5. Medicago begins human clinical testing with its avian flu pandemic vaccine
6. Medicago awarded contract by the U.S. Army to explore applications of its plant-based technology in renewable energy
7. Medicago to present at the U.S. Department of Health and Human Services Global Health Security Initiative Workshop
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. QMed, Inc. Reports July Medicare SNP Enrollments
10. Phlo Affiliate Reports Expanded Coverage to Oregon Border
11. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... PA & Boston, MA (PRWEB) July 28, 2014 ... collaboration agreements with two researchers to further develop potential ... deadly malignant brain tumor, in combination with their patented ... by ITI and Duke University, are based on the ... Chief, Division of Neurosurgery at The Preston Robert Tisch ...
(Date:7/28/2014)... , July 28, 2014  InterMune, Inc. (NASDAQ: ... release its second quarter 2014 financial results at the ... 2014. A live conference call and webcast will be hosted ... day. Interested investors and others may participate ... +1 212-231-2900 (international), conference ID#21728775. A replay of the webcast ...
(Date:7/25/2014)... (PRWEB) July 26, 2014 "Ischemic ... H2, 2014" provides data on the Ischemic Stroke ... provides elemental information and data relating to the ... , View full global Ischemic Stroke Research Report ... an overview of the trial numbers and their ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 According to ... "Biological Drugs Market - Global Industry Analysis, Size, Share, ... biological drugs market is estimated at USD 161,056.5 million ... CAGR of 10.1% from 2014 to 2020, to reach ... , The biological drugs market is witnessing a significant ...
Breaking Biology Technology:String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4InterMune to Release Second Quarter Financial Results on August 6 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 3Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3
... Fla. , April 23 Moffitt Cancer Center announces ... for selecting chemotherapy for Non Small Lung Cancer patients.  Each year, ... , , ... ERCC1 levels in cells to predict response to cisplatin-based chemotherapy.   ...
... April 22 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon Pharma" ... a complaint regarding its proposed merger with Datong Investment Inc ... Circuit for Palm Beach County , State of ... Yanlin Han , a director and Chief Executive Officer ...
... ... role of natural resources in food production. Technologies that grow more from less improve ... (PRWEB) ... has become a founding member of the Sustainability Consortium , an independent group ...
Cached Biology Technology:Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer 2Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer 3Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer 4Complaint Filed Regarding Proposed Merger 2Complaint Filed Regarding Proposed Merger 3Complaint Filed Regarding Proposed Merger 4Syngenta joins Sustainability Consortium as Founding Member 2Syngenta joins Sustainability Consortium as Founding Member 3
(Date:7/28/2014)... powerful new tool that can help advance the ... and renewable bioenergy, has been developed by researchers ... BioEnergy Institute (JBEI), a multi-institutional partnership led by ... researchers have developed an assay that enables scientists ... sugar transporters, critical components in the biosynthesis of ...
(Date:7/28/2014)... The Wyss Institute for Biologically Inspired Engineering at ... technology will be commercialized by a newly formed ... cosmetic, and personalized medicine products. The ... Office of Technology Development (OTD) and the start-up ... Institute,s automated human Organs-on-Chips platform. , "This ...
(Date:7/27/2014)... have survived the asteroid strike that wiped them out ... in history, scientists say. , A fresh study using ... palaeontologists to build a new narrative of the prehistoric ... found that in the few million years before a ... experiencing environmental upheaval. This included extensive volcanic activity, changing ...
Breaking Biology News(10 mins):How sweet it is 2How sweet it is 3Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 3Dinosaurs fell victim to perfect storm of events, study shows 2
... is part of a research team breaking new ground in ... $2.5 million grant from the National Institutes of Health, the ... for Xerostomia, or dry mouth, an inevitable consequence of radiation ... project is a collaborative effort between researchers at Rice University, ...
... Ore. Many studies have found that high levels of ... poor fitness and reduced chance of survival but recent ... be a good thing, often the difference between life and ... glucocorticoid hormones, which are part of the natural response to ...
... have identified 38 new genetic regions that are associated with ... total number of genetic regions associated with glucose and insulin ... type 2 diabetes. The researchers used a technology ... to follow-up on genome-wide association results. This technology, Metabochip, was ...
Cached Biology News:UD partner in NIH research project to produce artificial salivary glands 2UD partner in NIH research project to produce artificial salivary glands 3For young birds, getting stressed out can be a good thing 2Metabolic MAGIC 2Metabolic MAGIC 3
L1 Protein of Human Papilloma Virus Purified Anti-Viral-transformed cells clone CAMVIR-1, Isotype Mouse IgG 2a , 0.1 mg Consult technical datasheet for details....
... g. High quality kits and ... that give consistent and reliable ... tissues.Clean up samples from contaminants.Efficiently ... quantitate protein for first-dimension isoelectric ...
... The Varian Cary 50 ... reduces your cost per analysis ... throughput of the award-winning Cary ... analyze up to 384 samples ...
GOAT ANTI CARICA PAPAYA PAPAIN...
Biology Products: